News

Stay Updated! In The World Of Investments!
Sensex 49206.47 256.71 (0.52%)

Alkem Laboratories Latest News

30

Mar, 2021

Alkem Laboratories shines on agreeing to subscribe to partnership interest in ABCD Technologies LLP

Alkem Laboratories is currently trading at Rs. 2714.00, up by 64.90 points or 2.45% from its previous closing of Rs. 2649.10 on the BSE.

The scrip opened at Rs. 2650.00 and has touc...

Read More

30

Mar, 2021

Alkem Laboratories agrees to subscribe to partnership interest in ABCD Technologies LLP

Alkem Laboratories has agreed in principle to subscribe to a partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth services LLP). The Target entity is a recently incorporated limited liability p...

Read More

25

Mar, 2021

Alkem Laboratories jumps on the bourses

Alkem Laboratories is currently trading at Rs. 2647.75, up by 73.45 points or 2.85% from its previous closing of Rs. 2574.30 on the BSE.

The scrip opened at Rs. 2620.00 and has touc...

Read More

24

Mar, 2021

Alkem Laboratories trades slightly higher on agreeing to partner with Tata Memorial Centre

Alkem Laboratories is currently trading at Rs. 2606.10, up by 8.50 points or 0.33% from its previous closing of Rs. 2597.60 on the BSE.

The scrip opened at Rs. 2600.00 and...

Read More

23

Mar, 2021

Alkem Laboratories agrees to partner with Tata Memorial Centre

Alkem Laboratories (Alkem) has agreed to partner with Tata Memorial Centre (TMC) to establish an advanced Radiotherapy Facility as a part of the Homi Bhabha Cancer Hospital and Research Center (HBCHRC), Muzaffarpur....

Read More

15

Mar, 2021

Alkem Laboratories informs about press release

Alkem Laboratories has informed that Company has launched Brivaracetam in India under the brand name ‘Brivasure’, an affordable anti-epileptic drug for the treatment of Epilepsy in India. Brivasure has received auth...

Read More

15

Mar, 2021

Alkem Laboratories launches Brivasure

Alkem Laboratories (Alkem) has launched Brivasure, an affordable anti-epileptic drug for the treatment of Epilepsy in India. Brivasure, Alkem’s anti-epileptic drug (AED) is a generic version of the parent molecule. Alkem ...

Read More

03

Dec, 2020

Alkem Laboratories informs about disclosure

Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that it has enclosed disclosures of related party transactions, on a co...

Read More

27

Nov, 2020

Alkem Laboratories informs about postal ballot notice

Alkem Laboratories has informed that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration...

Read More

07

Aug, 2020

Alkem Laboratories informs about opening of trading window

With reference to its earlier communication dated 25th June, 2020 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June 2020) starting from 29th June, 2020 until the expiry of...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback